A novel DNMT3B subfamily, ΔDNMT3B, is the predominant form of DNMT3B in non-small cell lung cancer

International Journal of Oncology

Volumn 29, Issue 1, 2006, Pages 201-207

  Wang, Luo ^a   Wang, Jie ^d   Sun, Shiyong ^b   Rodriguez, Marivonne ^a   Yue, Ping ^b   Jang, Se Jin ^c   Mao, Li ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b EMORY UNIVERSITY   (United States)

^c Hanyang University   (South Korea)

^d PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

DNMT3B; Expression; NSCLC; Promoter; Splicing;

Indexed keywords

DNA; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNMT3B PROTEIN, HUMAN; ISOENZYME; LUCIFERASE; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL TRANSFORMATION; COMPARATIVE STUDY; DNA METHYLATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; PROMOTER REGION; REPORTER GENE; TUMOR CELL LINE;

ALTERNATIVE SPLICING; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DNA; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; ISOENZYMES; LUCIFERASES; LUNG NEOPLASMS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRANSFECTION;

EID: 33749020195     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.1.201     Document Type: Article

References (22)

1. Jaenisch R: DNA methylation and imprinting: why bother? Trends Genet 13: 323-329, 1997.
2. Jones P and Gonzalgo M: Altered DNA methylation and genome instability: a new pathway to cancer? Proc Natl Acad Sci USA 94: 2103-2105, 1997.
3. Robertson KD and Wolffe AP: DNA methylation in health and disease. Nat Rev Genet 1: 11-19, 2000.
4. Surani MA: Imprinting and the initiation of gene silencing in the germline. Cell 93: 309-312, 1998.
5. Monk M, Boubelik M and Lehnert S: Temporal and regional changes in DNA methylation in the embryonic, extra-embryonic, and germ cell lineages during mouse embryo development. Development 99: 371-382, 1987.
6. Okano M, Xie S and Li E: Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 19: 219-220, 1998. (Pubitemid 28309328)
7. Li E and Jaenisch R: DNA Alterations in Cancer. Ehrlich M (ed). Eaton Publishing, Natick, MA, pp351-365, 2000.
8. Okano M, Bell DW, Haber DA and Li E: DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99: 247-257, 1999.
9. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA and Jones PA: The human DNA methyltransferases (DNMTs)1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 27: 2291-2298, 1999.
10. Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H and Hrohoshi S: Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis. Proc Natl Acad Sci USA 99: 10060-10065, 2002.
11. Oue N, Kuraoka K, Kuniyasu H, Yokozaki H, Wakikawa A, Matsusaki K and Yasui W: DNA methylation status of hMLH1, p16(INK4a), and CDH1 is not associated with mRNA expression levels of DNA methyltransferase and DNA demethylase in gastric carcinomas. Oncol Rep 8: 1085-1089, 2001.
12. Yakushiji T, Uzawa K, Shibahara T, Noma H and Tanzawa H: Over-expression of DNA methyltransferases and CDKN2A gene methylation status in squamous cell carcinoma of the oral cavity. Int J Oncol 22: 1201-1207, 2003.
13. Sato M, Horio Y, Sekido Y, Minna JD, Shimokata K and Hasegawa Y: The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines. Oncogene 21: 4822-4829, 2002.
14. Liu K, Wang YF, Cantemir C and Muller MT: Endogenous assays of DNA methyltransferases: evidence for differential activities of DNMT1, DNMT2, and DNMT3 in mammalian cells in vivo. Mol Cell Biol 23: 2709-2719, 2003. (Pubitemid 36403072)
15. Bachman KE, Park BH, Rhee I, Rajagopalan H, Herman JG, Baylin SB, Kinzler KW and Vogelstein B: Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell 3: 89-95, 2003.
16. Rhee I, Jair KW, Yen RW, Lengauer C, Herman JG, Kinzler KW, Vogelstein B, Baylin SB and Schuebel KE: CpG methylation is maintained in human cancer cells lacking DNMT1. Nature 404: 1003-1007, 2000.
17. Leu YW, Rahmatpanah F, Shi H, Wei SH, Liu JC, Yan PS and Huang TH: Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation. Cancer Res 63: 6110-6115, 2003.
18. Jair KW, Bachman KE, Suzuki H, Ting AH, Rhee I, Yen RW, Baylin SB and Schuebel KE: De novo CpG island methylation in human cancer cells. Cancer Res 66: 682-692, 2006.
19. Girault I, Tozlu S, Lidereau R and Bieche I: Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. Clin Cancer Res 9: 4415-4422, 2003. (Pubitemid 37248399)
20. Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE, Cui H, Feinberg AP, Lengauer C, Kinzler KW, Baylin SB and Vogelstein B: DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416: 552-556, 2002.
21. Kim GD, Ni J, Kelesoglu N, Roberts RJ and Pradhan S: Cooperation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J 21: 4183-4195, 2002.
22. Shen H, Wang L, Spitz MR, Hong WK, Mao L and Wei Q: Identification of a new genetic variant in the novel Dnmt3b promoter and its association with promoter activity and risk of lung cancer. Cancer Res 62: 4992-4995, 2002.